• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰十二指肠切除术后胰腺导管腺癌患者教科书式预后与生存改善的相关性:一项回顾性研究

Association of textbook outcomes with improved survival in pancreatic ductal adenocarcinoma following pancreaticoduodenectomy: a retrospective study.

作者信息

Wang Haikuo, Hu Xiao, Yin Changjun, Zhou Dejiang, Li Zonglin, Ma Zifeng, Zhang Heyun

机构信息

Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Department of Gastrointestinal Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

Transl Gastroenterol Hepatol. 2024 Jul 11;9:38. doi: 10.21037/tgh-23-112. eCollection 2024.

DOI:10.21037/tgh-23-112
PMID:39091654
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11292086/
Abstract

BACKGROUND

Assessing the perioperative outcomes of pancreaticoduodenectomy (PD) based solely on individual complications is not comprehensive, and the association between perioperative outcomes and the long-term prognosis of individuals diagnosed with pancreatic ductal adenocarcinoma (PDAC) remains uncertain. Our study is designed to evaluate the impact of a novel composite indicator, textbook outcomes (TO), on the long-term prognosis of patients undergoing PD for PDAC.

METHODS

This study conducted a retrospective analysis of 139 patients who underwent PD for pathologically confirmed PDAC at our hospital between January 2018 and December 2021. After applying exclusion criteria, a total of 111 patients were included in the subsequent analysis. These patients were categorized into two groups: the non-TO group (n=42) and the TO group (n=69). The Kaplan-Meier survival curve was employed to describe the relationship between TO and disease-free survival (DFS) and overall survival (OS). Cox regression was employed to assess the impact of achieving TO on long-term survival. Logistic regression was employed to investigate the risk factors affecting the achievement of TO.

RESULTS

Out of the 111 PDAC patients, 69 (62.2%) achieved TO following PD. The achievement of TO significantly improved the OS of PDAC patients [P=0.03; hazard ratio (HR) =0.60; 95% confidence interval (CI): 0.37-0.83]. Cox regression analysis indicated that achieving TO was a protective factor for OS (P=0.04; HR =4.08; 95% CI: 1.07-15.61). Logistic regression analysis indicated that high amylase in drainage fluid on the third day after surgery (>1,300 U/L) was detrimental to achieve TO [odds ratio (OR) =0.10; 95% CI: 0.02-0.58; P=0.01], longer surgery durations (≥6.25 hours) was detrimental to achieve TO (OR =0.19; 95% CI: 0.06-0.54; P=0.002), and soft pancreatic texture was detrimental to achieve TO (OR =0.31; 95% CI: 0.10-0.93, P=0.04).

CONCLUSIONS

Achievement of TO significantly improves the OS of PDAC patients and has the potential to serve as a robust prognostic indicator. Looking ahead, it is highly necessary for TO to become a standard surgical quality control measure in hospitals.

摘要

背景

仅基于个体并发症来评估胰十二指肠切除术(PD)的围手术期结果并不全面,且围手术期结果与胰腺导管腺癌(PDAC)患者长期预后之间的关联仍不明确。我们的研究旨在评估一种新的综合指标——教科书式结果(TO)对接受PD治疗的PDAC患者长期预后的影响。

方法

本研究对2018年1月至2021年12月期间在我院接受PD治疗且病理确诊为PDAC的139例患者进行了回顾性分析。应用排除标准后,共有111例患者纳入后续分析。这些患者被分为两组:非TO组(n = 42)和TO组(n = 69)。采用Kaplan-Meier生存曲线描述TO与无病生存期(DFS)和总生存期(OS)之间的关系。采用Cox回归评估实现TO对长期生存的影响。采用Logistic回归研究影响实现TO的危险因素。

结果

111例PDAC患者中,69例(62.2%)在PD后实现了TO。实现TO显著改善了PDAC患者的OS[P = 0.03;风险比(HR)= 0.60;95%置信区间(CI):0.37 - 0.83]。Cox回归分析表明,实现TO是OS的保护因素(P = 0.04;HR = 4.08;95% CI:1.07 - 15.61)。Logistic回归分析表明,术后第三天引流液中淀粉酶水平高(>1300 U/L)不利于实现TO[比值比(OR)= 0.10;95% CI:0.02 - 0.58;P = 0.01],手术时间长(≥6.25小时)不利于实现TO(OR = 0.19;95% CI:0.06 - 0.54;P = 0.002),胰腺质地软不利于实现TO(OR = 0.31;95% CI:0.10 - 0.93,P = 0.04)。

结论

实现TO显著改善了PDAC患者的OS,并有潜力作为一个可靠的预后指标。展望未来,TO成为医院标准的手术质量控制措施非常必要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a242/11292086/ae592a3a3402/tgh-09-23-112-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a242/11292086/62bd57428bc4/tgh-09-23-112-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a242/11292086/af052cf30436/tgh-09-23-112-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a242/11292086/f9cb7fb2212f/tgh-09-23-112-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a242/11292086/ae592a3a3402/tgh-09-23-112-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a242/11292086/62bd57428bc4/tgh-09-23-112-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a242/11292086/af052cf30436/tgh-09-23-112-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a242/11292086/f9cb7fb2212f/tgh-09-23-112-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a242/11292086/ae592a3a3402/tgh-09-23-112-f4.jpg

相似文献

1
Association of textbook outcomes with improved survival in pancreatic ductal adenocarcinoma following pancreaticoduodenectomy: a retrospective study.胰十二指肠切除术后胰腺导管腺癌患者教科书式预后与生存改善的相关性:一项回顾性研究
Transl Gastroenterol Hepatol. 2024 Jul 11;9:38. doi: 10.21037/tgh-23-112. eCollection 2024.
2
Assessment of textbook oncologic outcomes following pancreaticoduodenectomy for pancreatic adenocarcinoma.评估胰腺腺癌胰十二指肠切除术后教科书式肿瘤学结局。
J Surg Oncol. 2020 May;121(6):936-944. doi: 10.1002/jso.25861. Epub 2020 Mar 2.
3
Postoperative infectious complications worsen oncologic outcomes following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.胰十二指肠切除术治疗胰腺导管腺癌术后感染性并发症可导致肿瘤学结果恶化。
J Surg Oncol. 2024 May;129(6):1097-1105. doi: 10.1002/jso.27595. Epub 2024 Feb 5.
4
Influence of sarcopenia on postoperative complications and long-term survival in pancreatic cancer patients undergone pancreaticoduodenectomy.肌肉减少症对接受胰十二指肠切除术的胰腺癌患者术后并发症及长期生存的影响。
Front Nutr. 2024 Jul 4;11:1434630. doi: 10.3389/fnut.2024.1434630. eCollection 2024.
5
Robotic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: Analysis of surgical outcomes and long-term prognosis in a high-volume center.机器人辅助胰十二指肠切除术治疗胰腺导管腺癌:高容量中心的手术结果及长期预后分析
Hepatobiliary Pancreat Dis Int. 2023 Apr;22(2):140-146. doi: 10.1016/j.hbpd.2022.09.006. Epub 2022 Sep 20.
6
Preoperative Alkaline Phosphatase-to-Cholesterol Ratio as a Predictor of Overall Survival in Pancreatic Ductal Adenocarcinoma Patients Undergoing Radical Pancreaticoduodenectomy.碱性磷酸酶-胆固醇比值对行胰十二指肠切除术的胰腺导管腺癌患者总生存的预测价值。
Med Sci Monit. 2021 Oct 2;27:e931868. doi: 10.12659/MSM.931868.
7
Comparison of clinical outcomes and prognosis between total pancreatectomy and pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.比较全胰切除术和胰十二指肠切除术治疗胰导管腺癌的临床结局和预后:系统评价和荟萃分析。
ANZ J Surg. 2023 Dec;93(12):2820-2827. doi: 10.1111/ans.18653. Epub 2023 Aug 23.
8
Neoadjuvant chemotherapy is associated with improved disease-free survival in pancreatic cancer patients undergoing pancreaticoduodenectomy with vascular resection.新辅助化疗与行胰十二指肠切除术联合血管切除的胰腺癌患者无病生存期的改善相关。
J Surg Oncol. 2024 Jul;130(1):72-82. doi: 10.1002/jso.27674. Epub 2024 May 10.
9
Impact of preoperative statin medication on long-term outcomes after pancreatoduodenectomy for ductal adenocarcinoma: an international multicentric cross-sectional study.术前他汀类药物治疗对胰十二指肠切除术治疗导管腺癌长期结局的影响:一项国际多中心横断面研究。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17007-17014. doi: 10.1007/s00432-023-05426-2. Epub 2023 Sep 23.
10
Outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) undergoing robotic (RPD) or open pancreaticoduodenectomies (OPD): a propensity score-weighted survival analysis.接受机器人(RPD)或开放胰十二指肠切除术(OPD)的胰腺导管腺癌(PDAC)患者的结局:倾向评分加权生存分析。
J Robot Surg. 2023 Jun;17(3):1085-1096. doi: 10.1007/s11701-022-01510-w. Epub 2022 Dec 30.

引用本文的文献

1
Risk factors of failure to achieve textbook outcome in patients after pancreatoduodenectomy: a systematic review and meta-analysis.胰十二指肠切除术后患者未达到教科书式预后的危险因素:一项系统评价和荟萃分析
Int J Surg. 2025 Apr 1;111(4):3093-3106. doi: 10.1097/JS9.0000000000002299.

本文引用的文献

1
Long-term outcomes and early recurrence after resection for metachronous pulmonary metastases from colorectal cancer.结直肠癌术后异时性肺转移切除的长期结果和早期复发。
Langenbecks Arch Surg. 2023 Dec 29;409(1):24. doi: 10.1007/s00423-023-03209-4.
2
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.胰腺癌:欧洲肿瘤内科学会临床实践指南之诊断、治疗及随访
Ann Oncol. 2023 Nov;34(11):987-1002. doi: 10.1016/j.annonc.2023.08.009. Epub 2023 Sep 9.
3
Textbook Outcome after Gastrectomy for Gastric Cancer Is Associated with Improved Overall and Disease-Free Survival.
胃癌胃切除术后的教科书式结局与总体生存率和无病生存率的提高相关。
J Clin Med. 2023 Aug 21;12(16):5419. doi: 10.3390/jcm12165419.
4
Stapler Method for Transection of the Pancreatic Parenchyma During Pancreatoduodenectomy: Prospective Study.胰十二指肠切除术中胰腺实质横断的吻合器方法:前瞻性研究
J Gastrointest Surg. 2023 Oct;27(10):2215-2217. doi: 10.1007/s11605-023-05813-7. Epub 2023 Aug 24.
5
Textbook outcome in colon carcinoma: implications for overall survival and disease-free survival.结肠癌的教科书结局:对总生存和无病生存的影响。
Langenbecks Arch Surg. 2023 May 30;408(1):218. doi: 10.1007/s00423-023-02949-7.
6
Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreatic Ductal Adenocarcinoma.主要术后并发症限制了接受胰十二指肠切除术的远端胆管癌或胰腺导管腺癌患者的辅助治疗。
Ann Surg Oncol. 2023 Aug;30(8):5027-5034. doi: 10.1245/s10434-023-13533-0. Epub 2023 May 20.
7
Association between textbook outcome and long-term survival after surgery for colorectal liver metastases.结直肠癌肝转移手术后教科书式预后与长期生存之间的关联。
Br J Surg. 2023 Sep 6;110(10):1284-1287. doi: 10.1093/bjs/znad133.
8
Targeting leukemia inhibitory factor in pancreatic adenocarcinoma.靶向胰腺腺癌中的白血病抑制因子。
Expert Opin Investig Drugs. 2023 May;32(5):387-399. doi: 10.1080/13543784.2023.2206558. Epub 2023 Apr 24.
9
Risk factors for achieving textbook outcome after laparoscopic duodenum-preserving total pancreatic head resection: a retrospective cohort study.腹腔镜保留十二指肠全胰头切除术术后达到教科书结果的风险因素:一项回顾性队列研究。
Int J Surg. 2023 Apr 1;109(4):698-706. doi: 10.1097/JS9.0000000000000251.
10
Textbook outcome: A novel metric in heart transplantation outcomes.教科书式结局:心脏移植结局中的一种新指标。
J Thorac Cardiovasc Surg. 2024 Mar;167(3):1077-1087.e13. doi: 10.1016/j.jtcvs.2023.02.019. Epub 2023 Feb 23.